The chromosome 6q22.33 region is associated with age at diagnosis of type 1 diabetes and disease risk in those diagnosed under 5 years of age

Aims/hypothesis The genetic risk of type 1 diabetes has been extensively studied. However, the genetic determinants of age at diagnosis (AAD) of type 1 diabetes remain relatively unexplained. Identification of AAD genes and pathways could provide insight into the earliest events in the disease proce...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Diabetologia 2018-01, Vol.61 (1), p.147-157
Hauptverfasser: Inshaw, Jamie R. J., Walker, Neil M., Wallace, Chris, Bottolo, Leonardo, Todd, John A.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 157
container_issue 1
container_start_page 147
container_title Diabetologia
container_volume 61
creator Inshaw, Jamie R. J.
Walker, Neil M.
Wallace, Chris
Bottolo, Leonardo
Todd, John A.
description Aims/hypothesis The genetic risk of type 1 diabetes has been extensively studied. However, the genetic determinants of age at diagnosis (AAD) of type 1 diabetes remain relatively unexplained. Identification of AAD genes and pathways could provide insight into the earliest events in the disease process. Methods Using ImmunoChip data from 15,696 cases, we aimed to identify regions in the genome associated with AAD. Results Two regions were convincingly associated with AAD ( p   0.001), the SNP most associated with AAD, rs72975913, was associated with susceptibility to type 1 diabetes in those individuals diagnosed at less than 5 years old ( p  = 2.3 × 10 −9 ). Conclusion/interpretation PTPRK and its neighbour THEMIS are required for early development of the thymus, which we can assume influences the initiation of autoimmunity. Non-HLA genes may only be detectable as risk factors for the disease in individuals diagnosed under the age 5 years because, after that period of immune development, their role in disease susceptibility has become redundant.
doi_str_mv 10.1007/s00125-017-4440-y
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5719131</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1948757109</sourcerecordid><originalsourceid>FETCH-LOGICAL-c470t-6afc7f3242519a4004d33a45adc1af94175e311701a8d7e78a14f2284838e7a93</originalsourceid><addsrcrecordid>eNp1kc9u1DAQxiMEokvhAbggS1y4pHhsZ-1ckFDFP6kSlyJxs6bJJHHZ2Fs7AeUleAaehSfDYZeqIHGyxvP7vpnRVxRPgZ8B5_pl4hxEVXLQpVKKl8u9YgNKipIrYe4Xm7Vdgtl-PikepXTNOZeV2j4sToSpjdRSb4rvlwOxZohhDCmMxLY3QpxJySL1LnjmEsOUQuNwopZ9c9PAsCeGE2sd9j6kDISOTcueGKx_VzRR1vg2F4kwEYsufWHOs2kIuTrKstnsW4qs-vljIYy_XbLz4-JBh7tET47vafHp7ZvL8_flxcd3H85fX5SN0nwqt9g1upNCiQpqVJyrVkpUFbYNYFcr0BVJAM0BTatJGwTVCWGUkYY01vK0eHXw3c9XI7UN-Snizu6jGzEuNqCzf3e8G2wfvtpKQw0SssGLo0EMNzOlyY4uNbTboacwJwu1MjrDfJ31_B_0OszR5_MypaVUSkiVKThQTQwpRepulwFu17TtIW2b07Zr2nbJmmd3r7hV_Ik3A-IApNzyPcU7o__r-gvTTrZp</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1973344234</pqid></control><display><type>article</type><title>The chromosome 6q22.33 region is associated with age at diagnosis of type 1 diabetes and disease risk in those diagnosed under 5 years of age</title><source>MEDLINE</source><source>SpringerLink Journals - AutoHoldings</source><creator>Inshaw, Jamie R. J. ; Walker, Neil M. ; Wallace, Chris ; Bottolo, Leonardo ; Todd, John A.</creator><creatorcontrib>Inshaw, Jamie R. J. ; Walker, Neil M. ; Wallace, Chris ; Bottolo, Leonardo ; Todd, John A.</creatorcontrib><description>Aims/hypothesis The genetic risk of type 1 diabetes has been extensively studied. However, the genetic determinants of age at diagnosis (AAD) of type 1 diabetes remain relatively unexplained. Identification of AAD genes and pathways could provide insight into the earliest events in the disease process. Methods Using ImmunoChip data from 15,696 cases, we aimed to identify regions in the genome associated with AAD. Results Two regions were convincingly associated with AAD ( p  &lt; 5 × 10 −8 ): the MHC on 6p21, and 6q22.33. Fine-mapping of 6q22.33 identified two AAD-associated haplotypes in the region nearest to the genes encoding protein tyrosine phosphatase receptor kappa ( PTPRK ) and thymocyte-expressed molecule involved in selection ( THEMIS ). We examined the susceptibility to type 1 diabetes at these SNPs by performing a meta-analysis including 19,510 control participants. Although these SNPs were not associated with type 1 diabetes overall ( p  &gt; 0.001), the SNP most associated with AAD, rs72975913, was associated with susceptibility to type 1 diabetes in those individuals diagnosed at less than 5 years old ( p  = 2.3 × 10 −9 ). Conclusion/interpretation PTPRK and its neighbour THEMIS are required for early development of the thymus, which we can assume influences the initiation of autoimmunity. Non-HLA genes may only be detectable as risk factors for the disease in individuals diagnosed under the age 5 years because, after that period of immune development, their role in disease susceptibility has become redundant.</description><identifier>ISSN: 0012-186X</identifier><identifier>EISSN: 1432-0428</identifier><identifier>DOI: 10.1007/s00125-017-4440-y</identifier><identifier>PMID: 28983737</identifier><language>eng</language><publisher>Berlin/Heidelberg: Springer Berlin Heidelberg</publisher><subject>Adult ; Age ; Autoimmunity ; Chromosome 6 ; Chromosomes - genetics ; Diabetes ; Diabetes mellitus ; Diabetes Mellitus, Type 1 - diagnosis ; Diabetes Mellitus, Type 1 - genetics ; Diagnosis ; Early Diagnosis ; Female ; Gene mapping ; Genetic Predisposition to Disease - genetics ; Haplotypes ; Haplotypes - genetics ; Health risk assessment ; Histocompatibility antigen HLA ; Human Physiology ; Humans ; Internal Medicine ; Major histocompatibility complex ; Male ; Medical diagnosis ; Medicine ; Medicine &amp; Public Health ; Metabolic Diseases ; Middle Aged ; Polymorphism, Single Nucleotide - genetics ; Protein-tyrosine-phosphatase ; Risk factors ; Single-nucleotide polymorphism ; Thymus</subject><ispartof>Diabetologia, 2018-01, Vol.61 (1), p.147-157</ispartof><rights>The Author(s) 2017</rights><rights>Diabetologia is a copyright of Springer, (2017). All Rights Reserved.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c470t-6afc7f3242519a4004d33a45adc1af94175e311701a8d7e78a14f2284838e7a93</citedby><cites>FETCH-LOGICAL-c470t-6afc7f3242519a4004d33a45adc1af94175e311701a8d7e78a14f2284838e7a93</cites><orcidid>0000-0002-7003-8966</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://link.springer.com/content/pdf/10.1007/s00125-017-4440-y$$EPDF$$P50$$Gspringer$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://link.springer.com/10.1007/s00125-017-4440-y$$EHTML$$P50$$Gspringer$$Hfree_for_read</linktohtml><link.rule.ids>230,314,780,784,885,27924,27925,41488,42557,51319</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/28983737$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Inshaw, Jamie R. J.</creatorcontrib><creatorcontrib>Walker, Neil M.</creatorcontrib><creatorcontrib>Wallace, Chris</creatorcontrib><creatorcontrib>Bottolo, Leonardo</creatorcontrib><creatorcontrib>Todd, John A.</creatorcontrib><title>The chromosome 6q22.33 region is associated with age at diagnosis of type 1 diabetes and disease risk in those diagnosed under 5 years of age</title><title>Diabetologia</title><addtitle>Diabetologia</addtitle><addtitle>Diabetologia</addtitle><description>Aims/hypothesis The genetic risk of type 1 diabetes has been extensively studied. However, the genetic determinants of age at diagnosis (AAD) of type 1 diabetes remain relatively unexplained. Identification of AAD genes and pathways could provide insight into the earliest events in the disease process. Methods Using ImmunoChip data from 15,696 cases, we aimed to identify regions in the genome associated with AAD. Results Two regions were convincingly associated with AAD ( p  &lt; 5 × 10 −8 ): the MHC on 6p21, and 6q22.33. Fine-mapping of 6q22.33 identified two AAD-associated haplotypes in the region nearest to the genes encoding protein tyrosine phosphatase receptor kappa ( PTPRK ) and thymocyte-expressed molecule involved in selection ( THEMIS ). We examined the susceptibility to type 1 diabetes at these SNPs by performing a meta-analysis including 19,510 control participants. Although these SNPs were not associated with type 1 diabetes overall ( p  &gt; 0.001), the SNP most associated with AAD, rs72975913, was associated with susceptibility to type 1 diabetes in those individuals diagnosed at less than 5 years old ( p  = 2.3 × 10 −9 ). Conclusion/interpretation PTPRK and its neighbour THEMIS are required for early development of the thymus, which we can assume influences the initiation of autoimmunity. Non-HLA genes may only be detectable as risk factors for the disease in individuals diagnosed under the age 5 years because, after that period of immune development, their role in disease susceptibility has become redundant.</description><subject>Adult</subject><subject>Age</subject><subject>Autoimmunity</subject><subject>Chromosome 6</subject><subject>Chromosomes - genetics</subject><subject>Diabetes</subject><subject>Diabetes mellitus</subject><subject>Diabetes Mellitus, Type 1 - diagnosis</subject><subject>Diabetes Mellitus, Type 1 - genetics</subject><subject>Diagnosis</subject><subject>Early Diagnosis</subject><subject>Female</subject><subject>Gene mapping</subject><subject>Genetic Predisposition to Disease - genetics</subject><subject>Haplotypes</subject><subject>Haplotypes - genetics</subject><subject>Health risk assessment</subject><subject>Histocompatibility antigen HLA</subject><subject>Human Physiology</subject><subject>Humans</subject><subject>Internal Medicine</subject><subject>Major histocompatibility complex</subject><subject>Male</subject><subject>Medical diagnosis</subject><subject>Medicine</subject><subject>Medicine &amp; Public Health</subject><subject>Metabolic Diseases</subject><subject>Middle Aged</subject><subject>Polymorphism, Single Nucleotide - genetics</subject><subject>Protein-tyrosine-phosphatase</subject><subject>Risk factors</subject><subject>Single-nucleotide polymorphism</subject><subject>Thymus</subject><issn>0012-186X</issn><issn>1432-0428</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2018</creationdate><recordtype>article</recordtype><sourceid>C6C</sourceid><sourceid>EIF</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><recordid>eNp1kc9u1DAQxiMEokvhAbggS1y4pHhsZ-1ckFDFP6kSlyJxs6bJJHHZ2Fs7AeUleAaehSfDYZeqIHGyxvP7vpnRVxRPgZ8B5_pl4hxEVXLQpVKKl8u9YgNKipIrYe4Xm7Vdgtl-PikepXTNOZeV2j4sToSpjdRSb4rvlwOxZohhDCmMxLY3QpxJySL1LnjmEsOUQuNwopZ9c9PAsCeGE2sd9j6kDISOTcueGKx_VzRR1vg2F4kwEYsufWHOs2kIuTrKstnsW4qs-vljIYy_XbLz4-JBh7tET47vafHp7ZvL8_flxcd3H85fX5SN0nwqt9g1upNCiQpqVJyrVkpUFbYNYFcr0BVJAM0BTatJGwTVCWGUkYY01vK0eHXw3c9XI7UN-Snizu6jGzEuNqCzf3e8G2wfvtpKQw0SssGLo0EMNzOlyY4uNbTboacwJwu1MjrDfJ31_B_0OszR5_MypaVUSkiVKThQTQwpRepulwFu17TtIW2b07Zr2nbJmmd3r7hV_Ik3A-IApNzyPcU7o__r-gvTTrZp</recordid><startdate>20180101</startdate><enddate>20180101</enddate><creator>Inshaw, Jamie R. J.</creator><creator>Walker, Neil M.</creator><creator>Wallace, Chris</creator><creator>Bottolo, Leonardo</creator><creator>Todd, John A.</creator><general>Springer Berlin Heidelberg</general><general>Springer Nature B.V</general><scope>C6C</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7T5</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8C1</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>H94</scope><scope>K9.</scope><scope>M0S</scope><scope>M1P</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>7X8</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0002-7003-8966</orcidid></search><sort><creationdate>20180101</creationdate><title>The chromosome 6q22.33 region is associated with age at diagnosis of type 1 diabetes and disease risk in those diagnosed under 5 years of age</title><author>Inshaw, Jamie R. J. ; Walker, Neil M. ; Wallace, Chris ; Bottolo, Leonardo ; Todd, John A.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c470t-6afc7f3242519a4004d33a45adc1af94175e311701a8d7e78a14f2284838e7a93</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2018</creationdate><topic>Adult</topic><topic>Age</topic><topic>Autoimmunity</topic><topic>Chromosome 6</topic><topic>Chromosomes - genetics</topic><topic>Diabetes</topic><topic>Diabetes mellitus</topic><topic>Diabetes Mellitus, Type 1 - diagnosis</topic><topic>Diabetes Mellitus, Type 1 - genetics</topic><topic>Diagnosis</topic><topic>Early Diagnosis</topic><topic>Female</topic><topic>Gene mapping</topic><topic>Genetic Predisposition to Disease - genetics</topic><topic>Haplotypes</topic><topic>Haplotypes - genetics</topic><topic>Health risk assessment</topic><topic>Histocompatibility antigen HLA</topic><topic>Human Physiology</topic><topic>Humans</topic><topic>Internal Medicine</topic><topic>Major histocompatibility complex</topic><topic>Male</topic><topic>Medical diagnosis</topic><topic>Medicine</topic><topic>Medicine &amp; Public Health</topic><topic>Metabolic Diseases</topic><topic>Middle Aged</topic><topic>Polymorphism, Single Nucleotide - genetics</topic><topic>Protein-tyrosine-phosphatase</topic><topic>Risk factors</topic><topic>Single-nucleotide polymorphism</topic><topic>Thymus</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Inshaw, Jamie R. J.</creatorcontrib><creatorcontrib>Walker, Neil M.</creatorcontrib><creatorcontrib>Wallace, Chris</creatorcontrib><creatorcontrib>Bottolo, Leonardo</creatorcontrib><creatorcontrib>Todd, John A.</creatorcontrib><collection>Springer Nature OA Free Journals</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Immunology Abstracts</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Public Health Database</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Diabetologia</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Inshaw, Jamie R. J.</au><au>Walker, Neil M.</au><au>Wallace, Chris</au><au>Bottolo, Leonardo</au><au>Todd, John A.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>The chromosome 6q22.33 region is associated with age at diagnosis of type 1 diabetes and disease risk in those diagnosed under 5 years of age</atitle><jtitle>Diabetologia</jtitle><stitle>Diabetologia</stitle><addtitle>Diabetologia</addtitle><date>2018-01-01</date><risdate>2018</risdate><volume>61</volume><issue>1</issue><spage>147</spage><epage>157</epage><pages>147-157</pages><issn>0012-186X</issn><eissn>1432-0428</eissn><abstract>Aims/hypothesis The genetic risk of type 1 diabetes has been extensively studied. However, the genetic determinants of age at diagnosis (AAD) of type 1 diabetes remain relatively unexplained. Identification of AAD genes and pathways could provide insight into the earliest events in the disease process. Methods Using ImmunoChip data from 15,696 cases, we aimed to identify regions in the genome associated with AAD. Results Two regions were convincingly associated with AAD ( p  &lt; 5 × 10 −8 ): the MHC on 6p21, and 6q22.33. Fine-mapping of 6q22.33 identified two AAD-associated haplotypes in the region nearest to the genes encoding protein tyrosine phosphatase receptor kappa ( PTPRK ) and thymocyte-expressed molecule involved in selection ( THEMIS ). We examined the susceptibility to type 1 diabetes at these SNPs by performing a meta-analysis including 19,510 control participants. Although these SNPs were not associated with type 1 diabetes overall ( p  &gt; 0.001), the SNP most associated with AAD, rs72975913, was associated with susceptibility to type 1 diabetes in those individuals diagnosed at less than 5 years old ( p  = 2.3 × 10 −9 ). Conclusion/interpretation PTPRK and its neighbour THEMIS are required for early development of the thymus, which we can assume influences the initiation of autoimmunity. Non-HLA genes may only be detectable as risk factors for the disease in individuals diagnosed under the age 5 years because, after that period of immune development, their role in disease susceptibility has become redundant.</abstract><cop>Berlin/Heidelberg</cop><pub>Springer Berlin Heidelberg</pub><pmid>28983737</pmid><doi>10.1007/s00125-017-4440-y</doi><tpages>11</tpages><orcidid>https://orcid.org/0000-0002-7003-8966</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0012-186X
ispartof Diabetologia, 2018-01, Vol.61 (1), p.147-157
issn 0012-186X
1432-0428
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5719131
source MEDLINE; SpringerLink Journals - AutoHoldings
subjects Adult
Age
Autoimmunity
Chromosome 6
Chromosomes - genetics
Diabetes
Diabetes mellitus
Diabetes Mellitus, Type 1 - diagnosis
Diabetes Mellitus, Type 1 - genetics
Diagnosis
Early Diagnosis
Female
Gene mapping
Genetic Predisposition to Disease - genetics
Haplotypes
Haplotypes - genetics
Health risk assessment
Histocompatibility antigen HLA
Human Physiology
Humans
Internal Medicine
Major histocompatibility complex
Male
Medical diagnosis
Medicine
Medicine & Public Health
Metabolic Diseases
Middle Aged
Polymorphism, Single Nucleotide - genetics
Protein-tyrosine-phosphatase
Risk factors
Single-nucleotide polymorphism
Thymus
title The chromosome 6q22.33 region is associated with age at diagnosis of type 1 diabetes and disease risk in those diagnosed under 5 years of age
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-26T18%3A04%3A10IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=The%20chromosome%206q22.33%20region%20is%20associated%20with%20age%20at%20diagnosis%20of%20type%201%20diabetes%20and%20disease%20risk%20in%20those%20diagnosed%20under%205%C2%A0years%20of%20age&rft.jtitle=Diabetologia&rft.au=Inshaw,%20Jamie%20R.%20J.&rft.date=2018-01-01&rft.volume=61&rft.issue=1&rft.spage=147&rft.epage=157&rft.pages=147-157&rft.issn=0012-186X&rft.eissn=1432-0428&rft_id=info:doi/10.1007/s00125-017-4440-y&rft_dat=%3Cproquest_pubme%3E1948757109%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1973344234&rft_id=info:pmid/28983737&rfr_iscdi=true